Related Experiment Video
Updated: Aug 27, 2025
05:24
Teratoma Generation in the Testis Capsule
Published on: November 7, 2011
20.9K
Alternative In Vivo Models to Study Teratoma
Michela Corsini1, Stefania Mitola2
1Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|September 26, 2022
Summary
Embryonic stem cells can form teratomas. This study compares the chick embryo chorioallantoic membrane (CAM) model to the traditional mouse model for testing these teratogenic properties.
Area of Science:
- Stem cell biology
- Developmental toxicology
- Translational medicine
Background:
- Embryonic stem cells (ESCs) possess the potential to form teratomas when transplanted in vivo.
- Controlling teratoma formation is crucial for the clinical application of stem cells in regenerative medicine.
- Current methods for assessing teratogenicity are time-consuming and resource-intensive.
Purpose of the Study:
- To evaluate the chick embryo chorioallantoic membrane (CAM) assay as a potential alternative model for teratogenicity testing.
- To compare the efficacy and efficiency of the CAM model against the established murine model for assessing the teratogenic potential of embryonic stem cells.
Main Methods:
- In vivo teratogenicity assessment using the established murine model.
- In vivo teratogenicity assessment using the emerging chick embryo chorioallantoic membrane (CAM) model.
- Comparative analysis of results obtained from both models.
Main Results:
- The study presents comparative data on teratoma formation in both murine and CAM models.
- Preliminary findings suggest the CAM model's potential as a viable alternative.
Conclusions:
- The chick embryo chorioallantoic membrane (CAM) model shows promise as a faster and potentially more efficient alternative for teratogenicity testing of embryonic stem cells.
- Further validation is needed, but the CAM model could accelerate stem cell research and therapeutic development.
